HeimVEEV • NYSE
add
Veeva Systems Inc
Við síðustu lokun
232,03 $
Dagbil
234,47 $ - 237,79 $
Árabil
170,25 $ - 258,93 $
Markaðsvirði
38,20 ma. USD
Meðalmagn
1,28 m.
V/H-hlutf.
54,33
A/V-hlutfall
-
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | jan. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 720,89 m. | 14,31% |
Rekstrarkostnaður | 351,47 m. | 9,35% |
Nettótekjur | 195,62 m. | 32,72% |
Hagnaðarhlutfall | 27,14 | 16,13% |
Hagnaður á hvern hlut | 1,74 | 26,09% |
EBITDA | 198,36 m. | 37,85% |
Virkt skatthlutfall | 20,20% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | jan. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 5,15 ma. | 27,87% |
Heildareignir | 7,34 ma. | 24,17% |
Heildarskuldir | 1,51 ma. | 19,06% |
Eigið fé alls | 5,83 ma. | — |
Útistandandi hlutabréf | 162,70 m. | — |
Eiginfjárgengi | 6,47 | — |
Arðsemi eigna | 6,83% | — |
Ávöxtun eigin fjár | 8,21% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | jan. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 195,62 m. | 32,72% |
Handbært fé frá rekstri | 69,54 m. | 20,38% |
Reiðufé frá fjárfestingum | -15,69 m. | 81,90% |
Reiðufé frá fjármögnun | 20,81 m. | 298,50% |
Breyting á handbæru fé | 74,27 m. | 284,65% |
Frjálst peningaflæði | 8,39 m. | -54,94% |
Um
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly-traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Framkvæmdastjóri
Stofnsett
2007
Höfuðstöðvar
Vefsvæði
Starfsfólk
7.291
